Pyxis Oncology, Inc.PYXSNASDAQ

Revenue (LTM)

$16M

Net Income (LTM)

$-77M

-4.8% YoY

Free Cash Flow

$-58M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	16
Gross Profit	-0	0	0	0	16
Operating Income	-13	-70↓440.7%	-123↓77.1%	-82↑33.4%	-89↓8.8%
Net Income	-13	-76↓492.3%	-121↓58.9%	-74↑38.9%	-77↓4.8%
EBITDA	-12	-69↓457.7%	-123↓77.8%	-80↑34.6%	-66↑18.4%
EPS Diluted	-0.37	-2.53↓583.8%	-3.57↓41.1%	-1.85↑48.2%	-1.32↑28.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	8	275↑3300.2%	179↓34.7%	10↓94.6%	19↑101.5%
Total Current Assets	8	279↑3339.1%	187↓33.0%	125↓33.2%	132↑6.3%
Total Assets	10	280↑2658.6%	211↓24.5%	174↓17.8%	157↓9.5%
Total Current Liabilities	4	19↑407.1%	32↑69.1%	26↓18.6%	18↓31.4%
Total Liabilities	26	19↓27.5%	51↑170.2%	48↓5.0%	36↓24.1%
Total Equity	-16	261↑1770.3%	161↓38.5%	126↓21.8%	121↓3.9%
Total Debt	1	0↓78.8%	19↑11367.3%	21↑12.7%	20↓5.3%
Net Debt	-7	-275↓3661.2%	-160↑41.6%	12↑107.3%	1↓93.8%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-10	-35↓250.3%	-89↓152.9%	-71↑20.8%	-58↑18.4%
Capital Expenditure	-1	-1↑63.6%	-6↓1085.0%	-7↓5.1%	-0↑96.5%
Free Cash Flow	-12	-36↓210.1%	-96↓166.9%	-77↑19.1%	-58↑25.2%
Stock-Based Comp	0	6↑14538.6%	16↑144.7%	17↑7.5%	13↓23.6%
Net Change in Cash	-12	268↑2425.1%	-96↓135.6%	-170↓77.5%	10↑105.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance